Reports on HIV/AIDS: 1990

NOVEMBER 30, 1990, MMWR, Vol. 39, RR-16 [inclusive page numbers]
and the Alcohol, Drug Abuse, and Mental Health Administration (ADAMHA),
have been used to estimate the types of HIV/AIDS therapy used by persons with
HIV infection (28-30).
3. CDC staff have begun efforts to estimate the proportion of HIV-infected children
whose HIV infection has been diagnosed, by comparing AIDS case surveillance
and HIV reporting with data from the national survey of childbearing women.
References
1. Public Health Service. Coolfont report: a PHS plan for prevention and control of AIDS and
the AIDS virus. Public Health Rep 1986;101:341-8.
2. Report of the Second Public Health Service AIDS Prevention and Control Conference. Public
Health Rep 1988;103(supp):10-8.
3. CDC. Estimates of HIV prevalence and projected AIDS cases: summary of a workshop,
October 31-November 1, 1989. MMWR 1990;39:110-2, 117-9.
4. CDC. Classification system for human T-lymphotropic virus type III/lymphadenopathyassociated virus infections. MMWR 1986;35:334-9.
5. CDC.' Revision of the CDC surveillance case definition for acquired immunodeficiency
syndrome. MMWR 1987;36(suppl no. 1S):1S-15S.
6. Stoneburner RL, Des Jarlais DC, Benezra D, et al. A larger spectrum of severe HIV-1 related
disease in intravenous drug users in New York City. Science 1988;242:916-9.
7. Buehler JW, Devine OJ, Berkelman RL, Chevarley FM. Impact of the human immunodeficiency virus epidemic on mortality trends in young men, United States. Am J Public Health
1990;80:1080-6.
8. Brookmeyer R, Damiano A. Statistical methods for short-term projections of AIDS incidence.
Stat Med 1989;8:23-34.
9. Brookmeyer R, Gail MH. A method for obtaining short-term projections and lower bounds
on the size of the AIDS epidemic. J Am Stat Assoc 1988;83:301-8.
10. CDC. Update: acquired immunodeficiency syndrome - United States, 1989. MMWR
1990;39:81-6.
11. CDC. Human immunodeficiency virus infection in the United States: a review of current
knowledge. MMWR 1987;36(S-6):1-48.
12. Gail MH, Rosenberg PS, Goedert JJ. Therapy may explain recent deficits in AIDS incidence.
J Acquir Immune Defic Syndr 1990;3:296-306.
13. Andrews EB, Creagh-Kirk T, Pattishall K, Tilson H. Number of patients treated withi
zidovudine in the limited distribution system, March-September 1987 [letter]. J Acquir
Immune Defic Syndr 1990;3:460.
14. Institute of Medicine, National Academy of Sciences. Confronting AIDS: directions for public
health, health care, and research. National Academy Press, Washington, DC, 1986: pp 69-70.
15. Dondero TJ, St Louis M, Anderson J, Petersen L, Pappaioanou M. Evaluation of the
estimated number of HIV infections using a spreadsheet model and empirical data [Abstract]. Abstracts from the V International Conference on AIDS June 4-9, 1989; Montreal,
Canada: 45.
16. McNeil JG, Brundage JF, Wann ZF, Burke DS, Miller RN, the Walter Reed Retrovirus
Research Group. Direct measurement of human immunodeficiency virus seroconversions in
a serially tested population of young adults in the United States Army, October 1985 to
October 1987. N Engl J Med 1989;320:1581-5.
17. Garland FC, Mayers DL, Hickey TM, Miller MR, Shaw EK, Gorham ED, Bigbee LR, McNally
MM. Incidence of human immunodeficiency virus seroconversion in U.S. Navy and Marine
Corps personnel, 1986 through 1988. JAMA 1989;262:3161-5.
18. Public Health Service. Special section: the sentinel HIV seroprevalence surveys. Public
Health Rep 1990;105:113-66.
19. CDC. National HIV seroprevalence surveys. Summary of results: data from surveillance
activities through 1989. U.S. Department of Health and Human Services, Public Health
Service, Centers for Disease Control. Document HIV/CID/9-90/006.
20. Brundage JF, McNeil JG, Miller RN, et al. The current distribution of CD4+ T-lymphocyte
counts among adults in the United States with human immunodeficiency virus infection:
estimates based on the experience of the U.S. Army. J Acquir Immune Defic Syndr
1990;3:92-4.

163